Why This Notice Exists

Over the last several quarters, elective medical practices advertising on Google Ads have experienced widespread and often sudden disruptions in performance.

These issues are not isolated to one specialty, market, or campaign type. Across the country, practices are reporting:

• Google Ads campaigns that previously performed consistently no longer delivering
• Sharp increases in cost per lead without corresponding quality improvements
• Ads or entire accounts being limited, paused, or placed into review cycles
• Landing pages being flagged despite no recent content changes
• Conflicting or unclear guidance from Google support and agency partners

In many cases, practices are being told this is due to “increased competition,” “seasonality,” or normal market fluctuations. Based on direct experience across multiple elective medical verticals, that explanation does not fully account for what is happening.

This notice exists to clarify the structural changes Google has made, why they matter, and why many practices are being affected at the same time.

What Changed in 2026: Five Confirmed Policy Updates

The sections below were added in September 2026. Each one is a documented change to Google’s published policy or enforcement, with a date and a source. They are listed in the order most likely to be affecting an elective practice right now.

1. Limited Ad Serving now covers all of Google Ads (August 2026)

This is the single most important change of the year for medical advertisers, and it is the one most often mistaken for a bidding problem. Under Limited Ad Serving, Google restricts how often an advertiser’s ads can show rather than disapproving them. In August 2026 Google expanded the policy from Search and YouTube to cover all Google Ads inventory, with rollout continuing through 2028.

Google states plainly that under this policy individual ads will not be disapproved. Qualification is assessed on account attributes, account maturity, advertiser verification status, history of policy compliance, ad format usage, user activity and reports, and advertiser industry. Healthcare is one of the industries carrying the most enforcement history.

The practical effect: an account can be fully approved, green across every column, and still lose most of its impression volume with nothing in the interface explaining why. Affected accounts receive an in-account notification and can appeal through Google’s Limited Ad Serving Appeals Form. If impressions fell off a cliff while every ad stayed approved, check for that notification before rebuilding a single campaign.

2. Appeals for older policy decisions were closed off (July 21, 2026)

As of July 21, 2026, the option to appeal a policy decision from inside the Google Ads account is no longer available for decisions made more than six months prior. The change applies retroactively to enforcement already sitting on an account, including suspensions, ad disapprovals and asset restrictions. Older decisions now require going through Google Ads support instead. Each ad also carries a cap of three appeals before support involvement becomes mandatory. See Google’s appeals limits update.

For a practice that has been quietly living with a disapproval from last year, the window to self-serve that fix has closed. That backlog is worth auditing this month rather than next year.

3. Demand Gen and Discovery may not serve at all for sensitive categories (June 2026)

In June 2026 Google clarified its Restricted targeting in Personalized advertising policy with a line that matters to every aesthetic and surgical practice running upper-funnel campaigns: Discovery and Demand Gen campaigns use advertiser-curated audiences by default, and “may be restricted from serving if targeting products and services that fall within sensitive interest categories.”

Health is a sensitive interest category. This is not a targeting warning, it is a serving warning. A Demand Gen campaign built for a cosmetic or hair restoration practice can be live, funded and approved while delivering almost nothing, and the campaign type itself is the reason.

4. Health became its own personalized advertising policy, with invasive procedures named explicitly

Google now maintains a dedicated Health in personalized advertising policy article. It defines invasive medical procedures as “cosmetic surgery, surgical procedures, or injections,” which places nearly every elective practice inside the sensitive category by definition rather than by interpretation.

Inside that category, the following are prohibited:

• Advertiser-curated audiences
• Customer Match
• Your data segments, including site visitors to treatment and procedure pages
• Audience expansion
• Lookalike segments

Predefined Google audiences remain available, because sensitive user signals are automatically excluded from them. Personalized health ads are not served to users under 18 at all. A practice whose remarketing list stopped growing did not hit a tracking bug. It hit this policy.

5. Healthcare ads entered Google’s AI Mode as a limited test (June 2026)

In June 2026 Google confirmed a limited test placing healthcare ads inside AI Mode for English-language queries in the United States, reported by Search Engine Land. Performance Max, AI Max with search term matching, Shopping and broad match campaigns are the eligible types.

One detail in the first phase deserves attention from regulated advertisers: ads using pinned assets or text disclaimers are excluded. Medical creative frequently depends on pinned headlines to hold required language in a fixed position. The structure that keeps an ad compliant is, for now, the structure that keeps it out of this surface. This is a test, not a settled policy, and it should be treated as a signal about direction rather than a reason to unpin anything.

What Did Not Change (And What You Can Safely Ignore)

Google published Healthcare and Medicines policy updates in April 2026 and July 2026. Both are country-specific expansions of prescription drug services: certified online pharmacies in India, and telemedicine providers in New Zealand and Spain. Neither one changes anything for a US elective practice.

This matters because those updates carry the “Healthcare and Medicines” label and will surface in any search for 2026 medical ad policy changes. A practice owner reading a summary that lists them alongside the changes above has been given five minutes of reading and no useful information. The updates that affect an aesthetic or hair restoration practice in the United States this year are the five in the previous section, none of which are filed under Healthcare and Medicines.

The Core Issue: Google Has Changed How Medical Advertising Is Classified and Evaluated

Google has significantly tightened how healthcare and medical advertisers are categorized, reviewed, and served within its advertising ecosystem. See Google’s healthcare and medicines advertising policy.

These changes go beyond keywords, bidding strategies, or creative testing. They affect:

• Account-level healthcare classification
• How medical intent is interpreted
• How landing pages are reviewed for compliance and eligibility
• How procedures, conditions, consultations, and outcomes are differentiated
• Whether ads are allowed to run consistently, intermittently, or at all

In practical terms, Google now evaluates medical advertisers more holistically than in previous years. This has created friction for practices whose advertising infrastructure was built under older assumptions.

Why This Is Not Just a Hair Restoration Issue

While hair restoration practices were among the first to feel these effects, the changes now clearly impact:

• Plastic and cosmetic surgery practices
• Facial plastic surgeons
• Med spas and aesthetic clinics
• Hybrid practices offering both surgical and non-surgical services

Any practice advertising elective medical services—especially those involving procedures, devices, or outcomes—is subject to increased scrutiny. This is not limited to one procedure type or specialty.

How Google’s Review Focus Has Shifted

Google’s current review systems place greater emphasis on:

1. Medical intent and sequencing

How information is presented matters more than ever. Pages that move too quickly into procedures, results, or outcomes are more likely to encounter delivery issues than pages that establish context, evaluation, and appropriateness first.

2. Procedure-forward vs. consult-forward framing

Ads and landing pages that lead directly with specific procedures often face more friction than those framed around consultations, assessments, or patient education. See Google’s destination requirements.

3. Claims and implied outcomes

Even when language appears compliant, Google’s systems increasingly evaluate implied promises, visual cues, and overall messaging structure. See Google’s misrepresentation policy.

4. Account and domain re-evaluation

Older accounts and domains are no longer reliably “grandfathered.” Google is actively reassessing advertisers against current standards, not historical approvals.

Why “Grandfathering” Is No Longer Reliable

Historically, many practices benefited from setups that continued to run simply because they were approved in the past. That buffer is disappearing.

Advertising systems are increasingly re-evaluating:

• Accounts
• Domains
• Landing pages
• Business classifications

As a result, waiting for things to “go back to normal” without structural adjustments has proven ineffective in most cases we’ve reviewed.

Why Many Agencies Are Struggling to Explain This

Most agencies are trained to troubleshoot:

• Keywords
• Bids
• Budgets
• Creative testing

Fewer agencies are equipped to interpret:

• Healthcare policy enforcement
• Account classification shifts
• Medical compliance at the system level
• Landing page sequencing from a regulatory perspective

As a result, many practices are receiving explanations that focus on surface-level metrics rather than underlying causes.

What This Means Going Forward

These changes represent a new operating environment for elective medical advertising on Google.

Practices that adapt successfully tend to:

• Reframe ads around evaluation and education
• Separate consultation intent from procedure detail
• Adjust landing page structure without sacrificing conversion quality
• Align messaging with how Google now interprets medical intent

Practices that do not adapt often experience:

• Rising acquisition costs
• Inconsistent lead flow
• Increased reliance on trial-and-error fixes
• Frustration without clarity

This is not about exploiting loopholes or bypassing rules. It is about operating within the updated reality of medical advertising on Google.

What to Audit in Your Account This Quarter

Five checks, in order. Each one maps to a specific change above, and each can be done from inside the account without a platform call.

1. Check for a Limited Ad Serving notification before touching anything else. It appears in the account, not on the ad. If it is there, impression volume is being capped by trust signals and no amount of bid or creative work will move it.
2. Pull every disapproval and asset restriction older than six months. Those can no longer be appealed from inside the account. Anything still sitting there needs a support path or a rebuild.
3. Look at what your Demand Gen and Discovery campaigns actually delivered, not what they were budgeted. Near-zero impressions on a funded campaign is the sensitive-category serving restriction, not a bidding problem.
4. Inventory every audience the account is using. Customer Match lists, site-visitor segments built from procedure pages, lookalikes and audience expansion are all prohibited for this category. Remove them rather than waiting for enforcement to find them.
5. Read your landing pages in sequence, top to bottom, as a reviewer would. Pages that establish candidacy and evaluation before procedure detail encounter less delivery friction than pages that open on the procedure. This is where most of the recoverable ground is.

A practice running its own campaigns can work through this list in an afternoon. If the account is managed, these are five questions worth putting to whoever manages it, and the answers will tell you quickly whether they are tracking policy enforcement or only tracking metrics. Our approach to paid search for aesthetic and elective medical practices starts with this audit rather than with campaign structure, and the same sequence drives how we handle hair restoration marketing, where these restrictions were felt earliest and hardest.

A Note on Timing

These shifts did not happen overnight, but their impact accelerated sharply through 2026. The August 2026 expansion of Limited Ad Serving is still rolling out and is not scheduled to complete until 2028, which means the enforcement environment described here is mid-change rather than settled.

Practices that recognize this as a structural change—not a temporary disruption—are better positioned to stabilize performance moving forward.

What’s Next

We walk through these changes in more detail in our live briefings, including how different practice types are being affected and what alignment looks like in this new environment. Dates for the next session are on our educational briefings page.

This notice is intended to provide clarity and context for practices navigating these changes today.